Nolan Sean P.
CIK 0001569926
Chief Executive OfficerDirector
Filings
13
Latest May 15, 2026
Issuers covered
2
Showing
13 of 13
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | +22.6% | +1.1% | +70.5% | -3.9% |
| 90 days | 3 | 0% | -35.1% | -36.9% | -31.1% | -37.3% |
| 180 days | 1 | 0% | -12.4% | -12.4% | -12.4% | -12.4% |
| 365 days | 1 | 100% | +18.7% | +18.7% | +18.7% | +18.7% |
Issuers
Companies where Nolan Sean P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | 8 | Jan 27, 2026 |
| VTR | Ventas, Inc. | 5 | May 15, 2026 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|